Atlas Trials

A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism

Clinical trial NCT01441804 · UNKNOWN

Trial details

NCT number
NCT01441804
Sponsor
Third Affiliated Hospital, Sun Yat-Sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2011-05-01
Primary completion
2014-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.